Angeles Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.55M Buy
37,583
+3,138
+9% +$362K 0.25% 42
2025
Q4
$3.66M Buy
34,445
+1,098
+3% +$103K 0.2% 51
2025
Q3
$2.8M Buy
33,347
+2,415
+8% +$199K 0.17% 52
2025
Q2
$2.45M Sell
30,932
-1,903
-6% -$151K 0.17% 51
2025
Q1
$2.95M Sell
32,835
-2,030
-6% -$190K 0.24% 44
2024
Q4
$3.47M Buy
34,865
+3,623
+12% +$374K 0.29% 39
2024
Q3
$3.55M Buy
31,242
+3,830
+14% +$455K 0.31% 35
2024
Q2
$3.39M Buy
27,412
+1,030
+4% +$133K 0.32% 35
2024
Q1
$3.48M Buy
26,382
+2,047
+8% +$252K 0.35% 31
2023
Q4
$2.65M Buy
24,335
+44
+0.2% +$4.57K 0.32% 30
2023
Q3
$2.5M Buy
24,291
+603
+3% +$65K 0.35% 29
2023
Q2
$2.73M Buy
23,688
+337
+1% +$38.3K 0.37% 28
2023
Q1
$2.48M Buy
23,351
+647
+3% +$69.9K 0.37% 30
2022
Q4
$2.52M Buy
22,704
+271
+1% +$27.7K 0.44% 29
2022
Q3
$1.93M Buy
22,433
+1,199
+6% +$107K 0.38% 31
2022
Q2
$1.94M Buy
21,234
+6
+0% +$532 0.39% 34
2022
Q1
$1.74M Buy
+21,228
New +$1.67M 0.33% 38

Other funds holding MRK

Angeles Wealth Management's MRK Position: Q1 2026 in Review

Angeles Wealth Management increased its Merck (MRK) stake by 9.1% in Q1 2026, buying an estimated $362K and bringing the position to 37,583 shares worth $4.55M. The position accounts for 0.25% of the portfolio, ranked #42.

Angeles Wealth Management first reported a position in MRK in Q1 2022 and has held it in 17 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Angeles Wealth Management held 37,583 shares of Merck worth $4.55M as of Q1 2026.
  • Angeles Wealth Management bought 3,138 Merck shares in Q1 2026, an estimated $362K.
  • Merck made up 0.25% of Angeles Wealth Management's portfolio in Q1 2026, its #42 holding.
  • Angeles Wealth Management first reported a position in Merck in Q1 2022 and has held it in 17 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.